Linda Evans

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study

Juan W. Valle, Harpreet Wasan, Philip J. Johnson et al. · British Journal of Cancer · 2009 · 264 citations · Full text

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

Matthew R. Sydes, Melissa Spears, Malcolm D. Mason et al. · Annals of Oncology · 2018 · 240 citations · Full text

Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report

Alicia Okines, Ruth E. Langley, Lindsay C Thompson et al. · Annals of Oncology · 2012 · 67 citations · Full text

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +10

High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia

L. El-Helw, Michael J. Seckl, R. Haynes et al. · British Journal of Cancer · 2005 · 47 citations · Full text